Kathy Bernstein, R.N.
About Kathy Bernstein, R.N.
Kathy Bernstein, R.N., is the Executive Regional Managed Markets Director at Alkermes, with extensive experience in healthcare and pharmaceutical industries.
Title and Current Role
Kathy Bernstein currently serves as the Executive Regional Managed Markets Director at Alkermes. In her role, she manages market strategies and supports addiction and behavioral health medication access with payers across New Jersey, Maryland, the District of Columbia, and Delaware.
Previous Experience at Shire Pharmaceuticals
From 2015 to 2016, Kathy worked as a Rare Disease Business Specialist at Shire Pharmaceuticals in Maryland. During this one-year tenure, she focused on developing strategies to support rare disease treatments.
Experience at MedImmune Specialty/AstraZeneca
Kathy Bernstein has held multiple roles at MedImmune Specialty/AstraZeneca, starting in 2000. She served as a Biotech Sales Specialist from 2000 to 2004 in Maryland, followed by a role as a Clinical Marketing Manager from 2004 to 2007. From 2007 to 2014, she was a Regional Account Manager in the Mid-Atlantic region, and subsequently, she held the role of Institutional Specialty Manager, Rare Disease from 2014 to 2015.
Background at Johns Hopkins Health Care
Kathy's early career includes a role as a Neonatal/Pediatric Case Manager at Johns Hopkins Health Care in Baltimore from 1996 to 2000. This position provided her with foundational experience in healthcare management and patient care.
Education at University of Virginia
Kathy Bernstein completed her undergraduate studies at the University of Virginia, where she earned a B.A. in English Language and Literature, General. Her education spanned from 1978 to 1982.
Expertise and Key Responsibilities
Kathy has extensive expertise in developing and executing market strategies for commercial, FFS, managed Medicaid, and Medicare health plans to maximize treatment access for patients. She has specialized experience in regional KOL engagement, standard of care development, specialty pharmacy distribution, and biotech institutional sales. Her work also includes experience with REMS and orphan drug launch projects.